These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15507286)

  • 1. Tests for lupus anticoagulant revisited.
    Derksen RH; de Groot PG
    Thromb Res; 2004; 114(5-6):521-6. PubMed ID: 15507286
    [No Abstract]   [Full Text] [Related]  

  • 2. Development of consensus guidelines for anticardiolipin and lupus anticoagulant testing.
    Wong RC; Adelstein S; Gillis D; Favaloro EJ
    Semin Thromb Hemost; 2005 Feb; 31(1):39-48. PubMed ID: 15706474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
    Exner T; Low J
    Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of anti-prothrombin antibodies for risk assessment of thromboembolism in patients with lupus anticoagulant.
    Sailer T; Vormittag R; Zoghlami C; Koder S; Quehenberger P; Male C; Pabinger I
    Thromb Res; 2007; 120(2):295-302. PubMed ID: 17328943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy.
    Harnett M; Kodali BS
    Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical consequences of antiphospholipid antibodies.
    Derksen RH; de Groot PG
    Neth J Med; 2004 Sep; 62(8):273-8. PubMed ID: 15588067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects.
    Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM
    Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved method for lupus anticoagulant detection.
    Alonso I; Vandermijnsbrugge F; Vanremoortele E; Bradstreet C; Efira A; Cantinieaux B
    Haematologica; 2005 Apr; 90(4):564-5. PubMed ID: 15820959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies--our experience.
    Srikrishna A; Sitalakshmi S; Devi S; Damodar P; Varghese J; Suresh J; Mathew T
    Indian J Pathol Microbiol; 2004 Apr; 47(2):174-7. PubMed ID: 16295461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of low levels of lupus anticoagulant antibodies.
    Villa P; Mira Y; Ferrando F; Vayá A; Aznar J
    Thromb Res; 2005; 116(5):447-9. PubMed ID: 15925399
    [No Abstract]   [Full Text] [Related]  

  • 12. The presence of IgG antibodies against beta2-glycoprotein I predicts the risk of thrombosis in patients with the lupus anticoagulant.
    Zoghlami-Rintelen C; Vormittag R; Sailer T; Lehr S; Quehenberger P; Rumpold H; Male C; Pabinger I
    J Thromb Haemost; 2005 Jun; 3(6):1160-5. PubMed ID: 15946204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lupus anticoagulant: case-based external quality assessment.
    van den Besselaar AM; Devreese KM; de Groot PG; Castel A
    J Clin Pathol; 2009 Aug; 62(8):731-4. PubMed ID: 19638545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary antiphospholipid syndrome].
    Popa A; Voinea L; Pop M; Stana D; Dascalu AM; Alexandrescu C; Ciuluvica R
    Oftalmologia; 2008; 52(1):13-7. PubMed ID: 18714484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Premature cardiovascular disease: no indication for the determination of antiphospholipid antibodies or lupus anticoagulant as a possible risk factor].
    Wierema TK; Stehouwer CD
    Ned Tijdschr Geneeskd; 2007 Mar; 151(13):735-8. PubMed ID: 17471773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiphosphatidylethanolamine antibodies are associated with an increased odds ratio for thrombosis. A multicenter study with the participation of the European Forum on antiphospholipid antibodies.
    Sanmarco M; Gayet S; Alessi MC; Audrain M; de Maistre E; Gris JC; de Groot PG; Hachulla E; Harlé JR; Sié P; Boffa MC
    Thromb Haemost; 2007 Jun; 97(6):949-54. PubMed ID: 17549297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lupus anticoagulant activity as a thrombosis risk factor in lung adenocarcinoma patients.
    De Meis E; Pinheiro VR; Loures MA; Kotouc MM; Zamboni MM; Guedes MT; Barros AS; Castilho IA; Levy RA
    Ann N Y Acad Sci; 2007 Jun; 1107():51-5. PubMed ID: 17804532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lupus anticoagulant is a risk factor for myocardial infarction (but not atherosclerosis): Hopkins Lupus Cohort.
    Petri M
    Thromb Res; 2004; 114(5-6):593-5. PubMed ID: 15507296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Activated Seven Lupus Anticoagulant (ASLA) test has comparable sensitivity to classical assays for screening of lupus anticoagulant.
    Marinuzzo M; Adamczuk Y; Varela ML; Pombo G; Forastiero R
    Thromb Haemost; 2005 May; 93(5):1007-9. PubMed ID: 15900652
    [No Abstract]   [Full Text] [Related]  

  • 20. Protein S deficiency in the presence of weak lupus anticoagulant resulting in right ventricular thrombosis.
    Flora D; Ghosh S; Yasin Z
    Clin Adv Hematol Oncol; 2004 Mar; 2(3):179. PubMed ID: 16166949
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.